BTSG vs. CAI: Which Stock Should Value Investors Buy Now?

Zacks
Abrir en Zacks
BTSG vs. CAI: Which Stock Should Value Investors Buy Now?

Investors looking for stocks in the Medical Services sector might want to consider either BrightSpring Health Services, Inc. (BTSG) or Caris Life Sciences,?Inc. (CAI). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.

We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits.

Currently, BrightSpring Health Services, Inc. has a Zacks Rank of #1 (Strong Buy), while Caris Life Sciences,?Inc. has a Zacks Rank of #3 (Hold). This means that BTSG's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. However, value investors will care about much more than just this.

Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.

The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.

BTSG currently has a forward P/E ratio of 35.08, while CAI has a forward P/E of 234.70. We also note that BTSG has a PEG ratio of 0.65. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. CAI currently has a PEG ratio of 8.03.

Another notable valuation metric for BTSG is its P/B ratio of 6.14. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, CAI has a P/B of 11.15.

These metrics, and several others, help BTSG earn a Value grade of B, while CAI has been given a Value grade of D.

BTSG has seen stronger estimate revision activity and sports more attractive valuation metrics than CAI, so it seems like value investors will conclude that BTSG is the superior option right now.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
BrightSpring Health Services, Inc. (BTSG): Free Stock Analysis Report
 
Caris Life Sciences,?Inc. (CAI): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research